×
Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.
RETNLB anticorps
RETNLB
Reactivité: Humain
ELISA, IHC
Hôte: Lapin
Polyclonal
unconjugated
N° du produit ABIN7235503
Détail du produit anti-RETNLB anticorps
(cache)
Antigène
Voir toutes RETNLB Anticorps
RETNLB
(Resistin Like beta (RETNLB))
Reactivité
Toutes les réactivités sur RETNLB Anticorps
Humain
Hôte
Toutes les hôtes sur RETNLB Anticorps
Lapin
Clonalité
Toutes les clonalités sur RETNLB Anticorps
Polyclonal
Conjugué
Tous les conjugués à travers RETNLB Anticorps
Cet anticorp RETNLB est non-conjugé
Application
Tous les applications à travers RETNLB Anticorps.
ELISA, Immunohistochemistry (IHC)
Attributs du produit
Polyclonal Antibody
Purification
Affinity purification
Immunogène
Recombinant protein of human RETNLB
Isotype
IgG
Top Product
Discover our top product RETNLB Anticorps primaire
Alternatives
(show)
Information d'application
(cache)
Indications d'application
IHC 1:50-1:200
Restrictions
For Research Use only
Stockage
(cache)
Format
Liquid
Concentration
0.3 mg/mL
Buffer
PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Store at -20°C. Avoid freeze / thaw cycles.
Détails sur RETNLB
(cache)
Antigène
RETNLB
(Resistin Like beta (RETNLB))
Autre désignation
RETNLB (RETNLB Produits )
Synonymes
anticorps FIZZ1, anticorps FIZZ2, anticorps HXCP2, anticorps RELM-beta, anticorps RELMb, anticorps RELMbeta, anticorps XCP2, anticorps RETNLB, anticorps 9030012B21Rik, anticorps Fizz2, anticorps Relmb, anticorps Xcp3, anticorps resistin like beta, anticorps RETNLB, anticorps Retnlb
Sujet
Resistin-like betais aproteinthat in humans is encoded by theRETNLBgene. An infusion of either resistin or RELMB in rats rapidly induced severe hepatic but not peripheral insulin resistance. Increases in circulating resistin or RELMB levels markedly stimulated hepatic glucose production despite the presence of fixed physiologic insulin levels. This enhanced rate of glucose output was due to increased flux through glucose-6-phosphatase. The results supported the notion that a novel family of fat- and gut-derived circulating proteins modulates hepatic insulin action.
UniProt
Q9BQ08
Pathways
Hormone Activity
Vus récemment
(cache)